No offense, but you common cents, seem to lack common cents. For a few reasons:
1. You personally have worked with Howard Phykitt and know that PHAR is a solid investment.
2. The product exists, it is pass the FDA situation, and now all that needs to happen is manufacturing. It is valued at $32M.
3. The company has put out PRs and is very transparent about what it is doing.
Yet with all this and I am sure you have more information than what I listed, you sell your shares? That does not make..common cents.
Those who believe will bring this fruition. I will continue buying shares and bring others to light about PHAR.
GO PHAR!
Market Data 
Markets 
AI
